| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA968606 | F | Cytotoxicity against human NCI-H2030 cells assessed as fraction of viable cells after 72 hrs relative to control | Homo sapiens | 13 | ALA1149823 | cell-based format | Scientific Literature | |
| 2. | ALA1646764 | F | Growth inhibition of human NCI-H2030 cells assessed as ATP level after 96 hrs by CellTiter-Glo assay | Homo sapiens | 1 | ALA1641579 | cell-based format | Scientific Literature | |
| 3. | ALA2363500 | F | SANGER: Inhibition of human NCI-H2030 cell growth in a cell viability assay. | Homo sapiens | 95 | ALA1201861 | cell-based format | Sanger Institute Genomics of Drug Sensitivity in Cancer | |
| 4. | ALA3241068 | F | In vitro antiproliferative activity against human NCI-H2030 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay | Homo sapiens | 3 | ALA3232734 | cell-based format | Scientific Literature | |
| 5. | ALA4418084 | F | Cytotoxicity against human NCI-H2030 cells assessed as reduction in cell viability incubated for 7 days | Homo sapiens | 1 | ALA4417634 | cell-based format | Patent Bioactivity Data | |
| 6. | ALA4721812 | F | Antiproliferative activity against human NCI-H2030 cells harboring KRAS G12C mutant assessed as reduction in cell viability | Homo sapiens | 1 | ALA4715824 | cell-based format | Scientific Literature | |
| 7. | ALA5054362 | F | Anticancer activity against human NCI-H2030 cells | Homo sapiens | 1 | ALA5053512 | cell-based format | Scientific Literature | |
| 8. | ALA5262740 | F | Cytotoxicity against human NCI-H2030 cells measured after 8 days | Homo sapiens | 1 | ALA5260810 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!